# Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

> **NCT02519387** · PHASE4 · COMPLETED · sponsor: **Mundipharma Pharmaceuticals Sdn. Bhd.** · enrollment: 78 (actual)

## Conditions studied

- Osteoarthritis
- Rheumatoid Arthritis
- Lower Back Pain
- Joint Pain
- Muscle Pain

## Interventions

- **DRUG:** Buprenorphine Transdermal Patch

## Key facts

- **NCT ID:** NCT02519387
- **Lead sponsor:** Mundipharma Pharmaceuticals Sdn. Bhd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2016-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02519387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02519387, "Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02519387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*